| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 05/08/2013 | CN103083654A Process for preparing human diploid cell rabies vaccine through Celligen310 bioreactor |
| 05/08/2013 | CN103083653A Method for producing classical swine fever live vaccine by using microcarrier high-density cell culture technology |
| 05/08/2013 | CN102604889B HEK (human embryonic kidney) 293 cell line applicable to serum-free culture and application thereof |
| 05/08/2013 | CN102002476B Human mucous membrane living tissue model cultured in vitro as well as building method and application thereof |
| 05/07/2013 | US8435543 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 05/07/2013 | CA2560185C Novel assay for the separation and quantification of hemagglutinin antigens |
| 05/07/2013 | CA2478125C Avian cell lines for the production of useful substances |
| 05/07/2013 | CA2360347C Improved expression of hiv polypeptides and production of virus-like particles |
| 05/02/2013 | WO2013063379A1 Cell line for production of adeno-associated virus |
| 05/02/2013 | WO2013059946A1 Device and method for bacterial culture and assay |
| 05/02/2013 | WO2012106356A3 Virus-like particles and methods of use |
| 05/02/2013 | US20130109077 Baculovirus-Mediated Transgene Expression in Both Mammalian and Insect Cells |
| 05/02/2013 | CA2853576A1 Device and method for bacterial culture and assay |
| 05/02/2013 | CA2853482A1 Cell line for production of adeno-associated virus |
| 05/01/2013 | CN103080322A Semi-stable production of lentiviral vectors |
| 05/01/2013 | CN103080304A Process for removing adventitious agents during the production of a virus in cell culture |
| 05/01/2013 | CN103074359A Method for showing foreign protein macromolecule on surface of T4 bacteriophage by using intracellular synchronous expression method |
| 05/01/2013 | CN103074306A Newcastle disease virus rNDV-H52AH9 and construction method and application thereof |
| 05/01/2013 | CN103074305A Recombinant varicella-zoster virus |
| 05/01/2013 | CN103074304A Method for culturing chicken pox-herpes zoster vaccine virus with high-level human diploid cell |
| 05/01/2013 | CN103074293A Culture medium for preparing influenza vaccine through MDCK cells and application method thereof |
| 05/01/2013 | CN102093983B Human diploid cell rabies vaccine virus seed and preparation method thereof |
| 05/01/2013 | CN101948516B Establishment and application of vaccinia virus vector-based reverse genetics system |
| 05/01/2013 | CN101490248B Method for influenza virus purification |
| 05/01/2013 | CN101481702B Recombinant vector containing polyhedrosis gene, and method for expressing and purifying protein |
| 04/30/2013 | US8431137 Influenza hemagglutinin and neuraminidase variants |
| 04/30/2013 | CA2458995C Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 04/30/2013 | CA2416633C Enhanced replication of hcv rna |
| 04/30/2013 | CA2399321C Adenovirus formulations |
| 04/25/2013 | WO2013059498A1 Mva vectors expressing polypeptides and having high level production in certain cell lines |
| 04/25/2013 | WO2013059168A2 Espirito santo virus and methods for detecting and preventing infection with the same |
| 04/25/2013 | WO2013058537A2 Living fatty material from which immunity is removed and method for manufacturing same |
| 04/25/2013 | WO2013057236A1 Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens |
| 04/25/2013 | WO2013030176A3 Live attenuated influenza virus |
| 04/25/2013 | US20130102055 Continuous flocculation deflocculation process for efficient harvesting of microalgae from aqueous solutions |
| 04/25/2013 | US20130102053 Multi Plasmid System For The Production Of Influenza Virus |
| 04/25/2013 | US20130101620 Recombinant varicella-zoster virus |
| 04/25/2013 | US20130101619 Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens |
| 04/25/2013 | US20130101612 Vaccine for enveloped viruses |
| 04/25/2013 | US20130101557 Recombinant Adenovirus Having Anti-Angiogenesis Activity |
| 04/25/2013 | CA2852610A1 Sample quantification by disc centrifugation |
| 04/25/2013 | CA2851658A1 Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens |
| 04/24/2013 | EP2583974A1 Pseudotyping of foamy viruses |
| 04/24/2013 | EP2582797A1 A method of producing bacteriophages |
| 04/24/2013 | EP2582796A2 Modified parvovirus having enhanced anti-tumour efficacy |
| 04/24/2013 | EP2582378A1 Novel strains of bacteriophages for the treatment of bacterial infections, particularly by strains of drug-resistant bacteria of the genus stenotrophomonas |
| 04/24/2013 | CN1869061B Peptidomimetic protease inhibitors |
| 04/24/2013 | CN103060376A Avian adenovirus transfer carrier and preparation method thereof |
| 04/24/2013 | CN103060331A Preparation method and application of capsid-protein-mutant double-stranded recombinant adeno-associated virus containing mediated-membrane-stabile CD40L gene |
| 04/24/2013 | CN103060279A Herbicide resistance protein and encoding genes thereof and application thereof |
| 04/24/2013 | CN103060278A Asia 1 type foot and mouth disease virus acid resistant mutant strains, capsid protein carried by same and encoding gene thereof and application |
| 04/24/2013 | CN103060277A Cultural method of phage agent for improving environment of aquatic water |
| 04/24/2013 | CN103060276A Preparation method for human diploid cell rabies vaccine virus solution |
| 04/24/2013 | CN103060262A Process for producing high-efficiency porcine pseudorabies live vaccine by using STC cell |
| 04/24/2013 | CN103060258A High-yield baculovirus cell line induced by carcinogen, preparation method and application |
| 04/24/2013 | CN102559760B Construction method for linearized shuttle vector BmBacmid |
| 04/24/2013 | CN102335422B Recombinant phage peculiar smell removal vaccine for boars |
| 04/24/2013 | CN102228686B Process for preparing veterinary rabies inactivated and freeze-dried vaccine through suspension culture cell |
| 04/24/2013 | CN102021149B Gene NSI deficit type respiratory syncytial virus and application thereof in treating lung cancer |
| 04/24/2013 | CN101861387B Novel bacteriophage and antibacterial composition containing the same |
| 04/24/2013 | CN101775374B Production method of porcine epidemic diarrhea virus |
| 04/24/2013 | CN101410519B Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 04/23/2013 | US8426188 Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof |
| 04/23/2013 | CA2690673C Methods of treating cell culture media for use in a bioreactor |
| 04/18/2013 | WO2011138251A8 Lentiviral vector based immunological compounds against malaria |
| 04/18/2013 | US20130095558 Process for producing recombinant human endostatin adenovirus |
| 04/18/2013 | US20130095556 Novel vesicular stomatitis virus and virus rescue system |
| 04/18/2013 | US20130095136 Tetravalent Dengue Vaccines |
| 04/18/2013 | US20130095135 Process for removing adventitious agents during the production of a virus in cell culture |
| 04/18/2013 | DE102004004043B4 Reinigung von hochmolekularen Verbindungen mittels Affinitätsmembranchromatographie Purification of high molecular weight compounds by means of affinity membrane chromatography |
| 04/18/2013 | CA2848658A1 Vaccines for human papilloma virus and methods for using the same |
| 04/17/2013 | CN1911445B Grippe primary generation susliks kidney cell multivalent vaccine and its preparation method |
| 04/17/2013 | CN103052399A Method for reducing DNA impurities in viral compositions |
| 04/17/2013 | CN103045646A Recombinant adeno-associated virus vector for co-expression of two independent anti-arthritis molecules TNFR-Fc and CTLA4-FasL, as well as construction method and application of recombinant adeno-associated virus vector |
| 04/17/2013 | CN103045545A Encephalitis virus protein, and coding gene and application thereof |
| 04/17/2013 | CN103045544A Recombinant pseudotyped baculovirus Bac-G-prM/E for preventing West Nile virus as well as vaccine and application thereof |
| 04/17/2013 | CN103045543A Swine transmissible gastroenteritis virus strain |
| 04/17/2013 | CN102533676B Virus recombinant vaccine A-NDV-LX/14 for newcastle disease and construction method thereof |
| 04/17/2013 | CN102430125B Heat-resistant stabilizer for chicken embryos fluid lyophilization, as well as preparation method and application thereof |
| 04/17/2013 | CN102417896B Phage for staphylococcus aureus and application thereof |
| 04/17/2013 | CN102304494B Duck hemorrhagic ovaritis virus strain, inactivated vaccine and preparation method thereof |
| 04/17/2013 | CN102002483B Hematopoietic targeted helper adenovirus and application thereof |
| 04/17/2013 | CN101831410B Preparation method of recombinant enterovirus 71 type virus-like particles |
| 04/16/2013 | US8420373 Permissive cells and uses thereof |
| 04/16/2013 | US8420372 Porcine adeno-associated viruses |
| 04/16/2013 | US8420076 Therapy or prophylaxis of Klebsiella pneumoniae infections with a lytic bacteriophage specifically against the K. pneumoniae |
| 04/16/2013 | CA2465973C Posh nucleic acids, polypeptides and related methods |
| 04/11/2013 | WO2013052832A2 Adenoviral vectors and methods of use |
| 04/11/2013 | WO2013052811A2 Adenoviral vectors and methods of use |
| 04/11/2013 | WO2013052643A1 Dimeric bacteriophage lysins |
| 04/11/2013 | WO2013052108A2 Methods and compositions for the treatment and diagnosis of ovarian cancer |
| 04/11/2013 | WO2013051772A1 Bacteriophage having bactericidal activity with respect to actinobacillus pleuropneumoniae |
| 04/11/2013 | WO2013050523A1 Viral vectors purification system |
| 04/11/2013 | WO2012047941A3 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 04/11/2013 | US20130089913 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 04/11/2013 | US20130089912 Methods and compositions for the stabilization of biologic material |
| 04/11/2013 | US20130089569 Recombinant mva capable of expressing structural hcv antigens |
| 04/11/2013 | US20130089567 Development of dengue virus vaccine components |
| 04/11/2013 | US20130089558 Dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| 04/11/2013 | CA2851251A1 Simian (gorilla) adenovirus or adenoviral vectors and methods of use |